SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-24-046361 from Empro Group Inc. (EMPG)

Empro Group Inc.
Date: Nov. 15, 2024 · CIK: 0002005569 · Accession: 0001493152-24-046361

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-282155

Referenced dates: August 22, 2024, November 4, 2024

Date
Nov. 15, 2024
Author
/s/
Form
CORRESP
Company
Empro Group Inc.

Letter

Division of Corporation Finance Office of Industrial Applications and Services RE: Empro Group Inc. Amendment No. 1 to Registration Statement on Form F-1 Filed October 16, 2024 File No. 333-282155

Dear Sir / Madam:

On behalf of our client, Empro Group, Inc. (the “Company”), a Cayman Islands exempted company with limited liability, we hereby submit this letter in response to the comments set forth in that certain letter dated November 4, 2024 from the staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “Commission”) to the Company, relating to Amendment No. 1 to the Registration Statement on Form F-1 that the Company filed with the Commission on October 16, 2024 (“Amendment No. 1”).

The Company is responding to the Staff’s comments by filing Amendment No. 2 to the Registration Statement (“Amendment No. 2”) that addresses the Staff’s comments, as more fully set forth below. For your convenience, the Staff’s comments have been retyped herein in bold.

Comment Business – Relationships with Partners, Regulators, and Government, page 66

We note your revised disclosure on page 46 that “[f]or the fiscal period ended June 30, 2024, . . . revenue derived from cosmetic and skincare accounted for approximately 41.62,” compared to your fiscal years ended December 31, 2023 and 2022 where “[r]evenue derived from cosmetic and skincare accounted for approximately 10% and 3% of our total revenue for those fiscal years, respectively.” We also note your response to prior comment 2 in our letter dated August 22, 2024, including that “[w]hile the Company believes that additional sales and revenues will be generated through these distribution agreements as the commercial rollout of SpaceLift continues, and that such sales and revenues, whether with respect to these agreements in aggregate or with respect to any particular agreement individually, will reach a meaningful level, it does not believe that any of these five distribution agreements, on an individual basis, currently constitutes a material agreement for the Company. When and if any of these distribution agreements does constitute a material agreement after the closing of this offering, the Company will file such agreement(s) as an exhibit to its applicable Securities Exchange Act reports, as required by law and SEC regulations.” Please file your distribution agreements as exhibits to the registration statement or provide a detailed legal analysis describing why you do not believe you are required to do so. Refer to Item 601(b)(10) of Regulation S-K.

Response

In response to the comment, we have added the Agreement for Supply of Goods effective April 1, 2024 between EMP Solution Sdn Bhd and Hong Kong Sa Sa (M) Sdn Bhd and the Agreement for Supply of Goods effective May 16, 2024 between EMP Solution Sdn Bhd and Sa Sa Cosmetic Company Limited as Exhibits 10.12 and 10.13 to Amendment No. 2. Revenue generated during the six month period ended June 30, 2024 from these two agreements was approximately MYR 367,007 ($82,706) and MYR 805,350 ($181,487), respectively, with such revenue continuing into the third and fourth fiscal quarters of 2024.

However, we are not filing either (A) the Exclusive Distributor Agreement dated December 25, 2023 with Pro Tek AS, (B) the Exclusive Distributor Agreement dated December 25, 2023 with Sash Trade or (C) the Exclusive Distributor Agreement dated December 25, 2023 with Aerofit Multiplus Pte Ltd due to the fact that we have determined that such agreements are not material for the Company at this time. Specifically, there were no revenues during the six month period ended June 30, 2024 under the agreement with Pro Tek due to the fact that the Company is currently updating the product labeling to ensure compliance with applicable regulations, there were no revenues during the six month period ended June 30, 2024 under the agreement with Sash Trade due to the fact that the product registration process is continuing in India, and revenues during the six month period ended June 30, 2024 under the agreement with Aerofit Multiplus were only approximately MYR 1,777.50 ($400). When and if any of the distributor agreements between EMP Solution and Pro Tek AS, Sash Trade or Aerofit Multiplus Pte Ltd constitutes a material agreement after the closing of this offering, the Company will file such agreement(s) as an exhibit to its applicable Securities Exchange Act reports, as required by law and SEC regulations, including Item 601(b)(10) of Reg. S-K.

For purposes of the above calculations, we have used a USD:MYR exchange rate of 1:4.4375 as of November 13, 2024.

If you have any further questions or comments, or would like to discuss this response letter, please feel free to call the undersigned at (212) 326-0468 or to email the undersigned at mcampoli@pryorcashman.com.

Sincerely,
/s/
Michael T. Campoli

Show Raw Text
CORRESP
1
filename1.htm

EMPRO
GROUP INC.

21,
Jalan 15/23, Tiong Nam Industry Park

40200
Shah Alam

Selangor,
Malaysia

BY
EDGAR

November
15, 2024

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

Office
of Industrial Applications and Services

Washington,
D.C. 20549

    Attn:
    Robert
    Augustin

    Katherine
    Bagley

    RE:
    Empro
    Group Inc.

    Amendment
    No. 1 to Registration Statement on Form F-1

    Filed
    October 16, 2024

    File
    No. 333-282155

Dear
Sir / Madam:

On
behalf of our client, Empro Group, Inc. (the “Company”), a Cayman Islands exempted company with limited liability,
we hereby submit this letter in response to the comments set forth in that certain letter dated November 4, 2024 from the staff (the
“Staff”) of the U.S. Securities and Exchange Commission (the “Commission”) to the Company, relating
to Amendment No. 1 to the Registration Statement on Form F-1 that the Company filed with the Commission on October 16, 2024 (“Amendment
No. 1”).

The
Company is responding to the Staff’s comments by filing Amendment No. 2 to the Registration Statement (“Amendment No.
2”) that addresses the Staff’s comments, as more fully set forth below. For your convenience, the Staff’s comments
have been retyped herein in bold.

    Comment
    1
    Business
    – Relationships with Partners, Regulators, and Government, page 66

We
note your revised disclosure on page 46 that “[f]or the fiscal period ended June 30, 2024, . . . revenue derived from cosmetic
and skincare accounted for approximately 41.62,” compared to your fiscal years ended December 31, 2023 and 2022 where “[r]evenue
derived from cosmetic and skincare accounted for approximately 10% and 3% of our total revenue for those fiscal years, respectively.”
We also note your response to prior comment 2 in our letter dated August 22, 2024, including that “[w]hile the Company believes
that additional sales and revenues will be generated through these distribution agreements as the commercial rollout of SpaceLift continues,
and that such sales and revenues, whether with respect to these agreements in aggregate or with respect to any particular agreement individually,
will reach a meaningful level, it does not believe that any of these five distribution agreements, on an individual basis, currently
constitutes a material agreement for the Company. When and if any of these distribution agreements does constitute a material agreement
after the closing of this offering, the Company will file such agreement(s) as an exhibit to its applicable Securities Exchange Act reports,
as required by law and SEC regulations.” Please file your distribution agreements as exhibits to the registration statement or
provide a detailed legal analysis describing why you do not believe you are required to do so. Refer to Item 601(b)(10) of Regulation
S-K.

Response

In
response to the comment, we have added the Agreement for Supply of Goods effective April 1, 2024 between EMP Solution Sdn Bhd and Hong
Kong Sa Sa (M) Sdn Bhd and the Agreement for Supply of Goods effective May 16, 2024 between EMP Solution Sdn Bhd and Sa Sa Cosmetic Company
Limited as Exhibits 10.12 and 10.13 to Amendment No. 2. Revenue generated during the six month period ended June 30, 2024 from these
two agreements was approximately MYR 367,007 ($82,706) and MYR 805,350 ($181,487), respectively, with such revenue continuing into the
third and fourth fiscal quarters of 2024.

However,
we are not filing either (A) the Exclusive Distributor Agreement dated December 25, 2023 with Pro Tek AS, (B) the Exclusive Distributor
Agreement dated December 25, 2023 with Sash Trade or (C) the Exclusive Distributor Agreement dated December 25, 2023 with Aerofit Multiplus
Pte Ltd due to the fact that we have determined that such agreements are not material for the Company at this time. Specifically, there
were no revenues during the six month period ended June 30, 2024 under the agreement with Pro Tek due to the fact that the Company is
currently updating the product labeling to ensure compliance with applicable regulations, there were no revenues during the six month
period ended June 30, 2024 under the agreement with Sash Trade due to the fact that the product registration process is continuing in
India, and revenues during the six month period ended June 30, 2024 under the agreement with Aerofit Multiplus were only approximately
MYR 1,777.50 ($400). When and if any of the distributor agreements between EMP Solution and Pro Tek AS, Sash Trade or Aerofit Multiplus
Pte Ltd constitutes a material agreement after the closing of this offering, the Company will file such agreement(s) as an exhibit to
its applicable Securities Exchange Act reports, as required by law and SEC regulations, including Item 601(b)(10) of Reg. S-K.

For
purposes of the above calculations, we have used a USD:MYR exchange rate of 1:4.4375 as of November 13, 2024.

If
you have any further questions or comments, or would like to discuss this response letter, please feel free to call the undersigned at
(212) 326-0468 or to email the undersigned at mcampoli@pryorcashman.com.

    Sincerely,

    /s/
    Michael T. Campoli

    Michael
    T. Campoli

    Pryor
    Cashman LLP

    cc:
    Yeoh
    Chee Wei